STAT+: FDA delays approval decision for Biogen’s Alzheimer’s treatment
The Food and Drug Administration is delaying its decision on Biogen’s closely watched Alzheimer’s drug…
Category: STAT+
STAT+: ‘A milestone in oncology’: Amgen’s KRAS-blocking drug proves effective for lung cancer patients in clinical trial
A drug from Amgen designed to block the cancer protein known as KRAS shrank tumors…
STAT+: Pharmalittle: U.S. wholesalers bid to distribute Covid-19 shots; U.S. drug prices were 2.5 times higher than in other countries
Top of the morning to you, and a fine one, it is. We can tell…
STAT+: ARCH raises $1.85 billion fund, planning to back more big companies
ARCH Venture Partners, the venture capital firm known for helping to arrange huge financings for…
STAT+: U.S. drug prices were more than double those in dozens of countries in 2018
As debate intensifies over the cost of medicines, a new analysis found that prescription drug…
STAT+: Advocacy groups urge Biden administration not to tap Woodcock as FDA commissioner
As the Biden White House attempts to fashion its health policies, a coalition of consumer…
STAT+: Pharma is only ‘inching forward’ in boosting access to medicines in low-income countries
Like the proverbial tortoise, a new analysis finds that while the pharmaceutical industry is taking…
.jpg)
STAT+: Pharmalittle: EU and AstraZeneca clash over Covid-19 vaccine; J&J is bullish about vaccine supplies
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT+: Senate rules could pose hurdles for vaccine funds
WASHINGTON — Progressive Democrats in the Senate are hoping to use a streamlined process that…
STAT+: This professor wrote a manual for using a little-known federal law for lowering drug prices
One of the priorities of the new Biden administration is to tackle the cost of…
STAT+: FTC sues drug makers over allegedly illegal deal over an opioid painkiller
For the second time, the Federal Trade Commission has filed a lawsuit alleging Endo International…
STAT+: Pharmalittle: Regeneron says its antibody prevented Covid-19 in a trial; EU threatens to impose vaccine export controls
Rise and shine, folks, another busy day is on the way. We can tell because…
STAT+: European Ombudsman probes failure to disclose Covid-19 vaccine contracts
In response to concerns that key terms of Covid-19 vaccine deals remain hidden, the European…
STAT+: Pharmalittle: Merck halts development of Covid-19 vaccines; Moderna starts work on booster shot to combat variants
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Aurinia secures FDA drug approval for autoimmune kidney disease, with label offering stronger patent protection
Aurinia Pharmaceuticals won approval from the Food and Drug Administration on Friday evening to market…
STAT+: PhRMA sues to block Trump administration 340B rule
WASHINGTON — The trade group for the pharmaceutical industry on Friday sued to block a …
STAT+: Pharmalittle: Pfizer agrees to supply Covid-19 vaccine to WHO Covax program; FDA approves first injectable HIV medicine
And so, another working week will soon draw to a close. Not a moment too…
FDA approves first monthly injectable medicine to treat HIV infection
In a move that could transform HIV treatment, the Food and Drug Administration has approved…
STAT+: Canada’s drug makers rattle their sabers over a government plan to control medicine spending
A majority of pharmaceutical executives in Canada say new regulations designed to cut prescription drug…
STAT+: Pharmalittle: Lilly says its antibody prevented Covid-19 in a trial; EU and Pfizer clash over vaccine delays
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: The CEO of Mark Cuban’s generics company talks drug prices, manufacturing, and his famous boss
In a surprise move, Mark Cuban last week announced plans to enter the generic drug…
STAT+: How Teladoc is teeing itself up to dominate in telehealth after the pandemic subsides
Teladoc is teeing itself up to remain a dominant digital health provider long after the…
STAT+: Biden is set to block dozens of Trump’s last-minute health regulations
WASHINGTON — President Biden is set to freeze a spate of last-minute Trump administration regulations…
STAT+: How much? Hospitals mark up some medicines by 250% on average
As Americans grapple with the rising cost of prescription drugs, a new analysis found that…
Longtime Becerra aide and two health policy experts to be tapped for key posts
WASHINGTON — President-elect Biden and his top health deputies are expected to make a slew…
STAT+: Pharmalittle: Pfizer and BioNTech say vaccine is effective against Covid-19 variant; U.S. to join COVAX initiative
Top of the morning to you, and a fine one it is, as the much-discussed…
STAT+: Biotech’s presence on new social media app Clubhouse is growing
For years, Twitter has been biotech’s social media app of choice. But the industry appears…
STAT+: After Moderna’s medical miracle, some investors step back
Moderna performed a miracle last year: The Cambridge biotech company, which hadn’t put a product…
STAT+: STAT+ Conversations: What to watch in a Biden White House and a new Congress
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: U.S. health officials seek more use of Covid-19 antibody drugs; Pfizer to reduce vaccine supplies to Europe
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Family medicine residents don’t interact with pharma as much as they once did
Amid concerns about pharmaceutical industry influence on physicians, a new survey finds fewer family medicine…
STAT+: Will the FTC get tougher on pharma business practices under the Biden administration?
As the Biden administration begins setting priorities, the Federal Trade Commission is poised to take…
STAT+: After repeated delays, Trump’s HHS punts on oversight of a massive Covid-19 response fund for hospitals
WASHINGTON — The Department of Health and Human Services acted with lightning speed to send…
STAT+: Maryland Senate overrides governor’s veto of prescription drug affordability board
In response to the rising cost of medicines, the Maryland state Senate overrode a veto…
STAT+: Pharmalittle: Biden taps Kessler to lead Operation Warp Speed; Trump administration seeks term limits on top FDA, CDC scientists
And so, another working week will soon come to a close. Not a moment too…
STAT+: Aurinia in ‘show-me phase’ as FDA nears approval decision on autoimmune kidney disease drug
Next week, the Food and Drug Administration is expected to approve a new medicine from…
STAT+: Medicare Part D spent twice what the VA paid for the same drugs
Medicare Part D spent more than twice as much on hundreds of prescription drugs than…
STAT+: Drug makers sue HHS over a discount program serving low-income populations
In a clutch of lawsuits, three drug makers argue the federal government is wrong to…
STAT+: Pharmalittle: J&J Covid-19 vaccine data show some immunity after one dose; Biden may tap Sharfstein to run the FDA
Top of the morning to you, and a fine one it is. Despite the perennial…
STAT+: Former Merck employee arrested for stealing trade secrets on cancer research
A former Merck (MRK) cancer researcher was arrested and charged with stealing a raft of…
STAT+: What comes after the telehealth boom? Hybrid care models are drawing investor interest
Buoyed by the pandemic, 2020 was undoubtedly the year that telehealth turned the corner to…
STAT+: ‘This is the foundation’: Health tech leaders discuss access, inequity, and community at CES
For all the focus on digital health at the Consumer Electronics Show for the past…
STAT+: Mark Cuban wades into the generic drug shark tank with a new company
Mark Cuban turns down new business opportunities on Shark Tank by declaring “I’m out!” But…
STAT+: 4 steps for AI developers to build trust in their clinical tools
As health systems deploy new tools that predict patients’ risk of serious medical outcomes, many…
STAT+: Sana Biotechnology, filing for IPO, aims for astronomical valuation
After years of rumors, Sana Biotechnology is positioning itself to file for an initial public…
STAT+: Pharmalittle: J&J Covid-19 vaccine production is behind schedule; Slaoui resigns from Operation Warp Speed
Rise and shine, everyone, the middle of the week is already here, which means we…
STAT+: Health tech experts explain why trust is crucial for clinical AI tools
It was a slight departure from the usual Consumer Electronics Show panel: Rather than touting…
STAT+: Endocrinologists urge federal lawmakers to act to lower insulin costs
Amid ongoing concerns over the cost of insulin, a leading physicians group is calling for…
STAT+: After repeated FDA rejections, key investor writes down stake in former diabetes unicorn Intarcia Therapeutics
Intarcia Therapeutics, a one-time biotech unicorn that has been unable to secure approval for a…
STAT+: Middlemen sue to block a signature Trump drug pricing proposal
WASHINGTON — The Pharmaceutical Care Management Association, which represents drug middlemen in Washington, filed a…